C
CoreValve
Developer of a minimally invasive heart valve replacement
About CoreValve
CoreValve is a medical device company that was acquired by Medtronic in 2009 for $700 million. The company specializes in transcatheter aortic valve replacement (TAVR) systems, which are minimally invasive procedures to replace a diseased aortic valve.
The CoreValve system is designed for patients with severe aortic stenosis who are at high risk for open-heart surgery. The system is delivered through a catheter, which is inserted into an artery in the leg or chest and guided to the heart. The new valve is then deployed, pushing the old valve out of the way and taking over the function of regulating blood flow.
The company's flagship product is the CoreValve Evolut PRO+ system, which is the latest generation of the CoreValve platform. The Evolut PRO+ system features a self-expanding nitinol frame and a porcine pericardial tissue valve. The system is designed to provide excellent hemodynamics, low rates of paravalvular leak, and a low risk of pacemaker implantation.
CoreValve's products are sold to hospitals and other healthcare facilities around the world. The company's primary customers are interventional cardiologists and cardiac surgeons.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2001
- Headquarters
- United States
- Open positions
- None listed
- Dealroom signal
- 20.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Developer Tools, Biotechnology, Cardiology and cardiovascular, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Apr 2009 | $700M | $700M | Medtronic | — |
| SERIES COther financing | Mar 2007 | $33M | $132M | Apax Partners · Sofinnova Partners · HealthCap · Maverick Ventures | — |
Growth signals
Latest recorded traffic for CoreValve is 60 monthly website visits, down 92.6% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Sofinnova Partners
HealthCap
Apax Partners
Series B and later1 investor entered at this stage
Other known investors1 additional known investor
Medtronic
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about CoreValve on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CoreValve’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.